English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Vika/vox, a novel efficient and specific Cre/loxP-like site-specific recombination system.

Karimova, M., Abi-Ghanem, J., Berger, N., Surendranath, V., Pisabarro, M. T., & Buchholz, F. (2013). Vika/vox, a novel efficient and specific Cre/loxP-like site-specific recombination system. Nucleic Acids Research, 41(2): e37.

Item is

Files

show Files

Locators

show

Creators

hide
 Creators:
Karimova, Madina1, Author           
Abi-Ghanem, Josephine, Author
Berger, Nicolas1, Author           
Surendranath, Vineeth1, Author           
Pisabarro, Maria Teresa2, Author
Buchholz, Frank1, Author           
Affiliations:
1Max Planck Institute of Molecular Cell Biology and Genetics, Max Planck Society, ou_2340692              
2Max Planck Society, ou_persistent13              

Content

hide
Free keywords: -
 Abstract: Targeted genome engineering has become an important research area for diverse disciplines, with site-specific recombinases (SSRs) being among the most popular genome engineering tools. Their ability to trigger excision, integration, inversion and translocation has made SSRs an invaluable tool to manipulate DNA in vitro and in vivo. However, sophisticated strategies that combine different SSR systems are ever increasing. Hence, the demand for additional precise and efficient recombinases is dictated by the increasing complexity of the genetic studies. Here, we describe a novel site-specific recombination system designated Vika/vox. Vika originates from a degenerate bacteriophage of Vibrio coralliilyticus and shares low sequence similarity to other tyrosine recombinases, but functionally carries out a similar type of reaction. We demonstrate that Vika is highly specific in catalyzing vox recombination without recombining target sites from other SSR systems. We also compare the recombination activity of Vika/vox with other SSR systems, providing a guideline for deciding on the most suitable enzyme for a particular application and demonstrate that Vika expression does not cause cytotoxicity in mammalian cells. Our results show that Vika/vox is a novel powerful and safe instrument in the 'genetic toolbox' that can be used alone or in combination with other SSRs in heterologous hosts.

Details

hide
Language(s):
 Dates: 2013
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: eDoc: 688473
Other: 5211
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

hide
Title: Nucleic Acids Research
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 41 (2) Sequence Number: e37 Start / End Page: - Identifier: -